Home

NASDAQ:BIAF Stock Quote

1.0900
+0.8300 (319.23%)

bioAffinity Technologies, Inc. is a biotechnology company focused on developing innovative diagnostic and therapeutic solutions for the early detection and treatment of cancer

The company leverages its proprietary technologies to create advanced cellular and molecular products aimed at improving patient outcomes, particularly in areas where traditional methods fall short. By harnessing the power of biological mechanisms, bioAffinity seeks to provide healthcare professionals with novel tools for identifying cancer at its earliest stages and tailoring personalized treatment plans for patients.

SummaryNewsPress ReleasesChartHistoricalFAQ
Curious about the most active stocks on Tuesday?chartmill.com
Curious about the most active stocks on Tuesday? Find out which stocks are dominating the market action!
Via Chartmill · April 1, 2025
These stocks have an unusual volume in today's sessionchartmill.com
Volume analysis on 2025-04-01: stocks with an unusual volume in today's session.
Via Chartmill · April 1, 2025
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · April 1, 2025
Nasdaq Surges 1%; US Construction Spending Rises In Februarybenzinga.com
Via Benzinga · April 1, 2025
Dow Dips Over 400 Points; ISM Manufacturing PMI Falls In Marchbenzinga.com
Via Benzinga · April 1, 2025
What's Going On With BioAffinity Shares Tuesday?benzinga.com
BioAffinity shares are moving higher on Tuesday after the company reported 2024 fiscal-year earnings, showing multiple year-over-year increases.
Via Benzinga · April 1, 2025
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · April 1, 2025
Why PVH Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · April 1, 2025
US Stocks Likely To Open Mixed After Disappointing Q1 Performance: 'April Does Better After A Weak Q1,' Says Expertbenzinga.com
U.S. stock futures were swinging between gains and losses on Tuesday after a mixed session on Monday. Futures of major benchmark indices were mixed in premarket trading. President Donald Trump‘s “Liberation Day”, the term he’s used for April 2nd, the day of incoming reciprocal tariffs, preceded a drop in stock prices.
Via Benzinga · April 1, 2025
What's going on in today's after hours sessionchartmill.com
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via Chartmill · March 31, 2025
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · March 31, 2025
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · March 18, 2025
Monday's session: top gainers and loserschartmill.com
Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session.
Via Chartmill · March 17, 2025
Let's have a look at the top gainers and losers in the middle of the day of today's session.chartmill.com
Intrigued by the market activity in the middle of the day on Monday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · March 17, 2025
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · March 17, 2025
Traders are paying attention to the gapping stocks in Monday's session.chartmill.com
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps.
Via Chartmill · March 17, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 1, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · October 23, 2024
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · October 18, 2024
Are Pharma Stocks Harmful To Your Financial Health ?talkmarkets.com
It seems time for the Securities and Exchange Commission to oversee stock advertising and consider a ban, or at least a danger warning label.
Via Talk Markets · October 9, 2024
BIAF Stock Earnings: bioAffinity Technologies Reported Results for Q2 2024investorplace.com
bioAffinity Technologies just reported results for the second quarter of 2024.
Via InvestorPlace · August 14, 2024
Crude Oil Falls Sharply; Exxon Mobil Earnings Top Viewsbenzinga.com
Via Benzinga · August 2, 2024
Nasdaq Tumbles 3%; US Economy Adds 114,000 Jobs In Julybenzinga.com
Via Benzinga · August 2, 2024
Dow Dips Over 400 Points; Apple Posts Upbeat Earningsbenzinga.com
Via Benzinga · August 2, 2024
BIAF Stock Earnings: bioAffinity Technologies Reported Results for Q1 2024investorplace.com
bioAffinity Technologies just reported results for the first quarter of 2024.
Via InvestorPlace · May 15, 2024